These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 18476957)

  • 21. Resiquimod, a topical drug for viral skin lesions and skin cancer.
    Meyer T; Surber C; French LE; Stockfleth E
    Expert Opin Investig Drugs; 2013 Jan; 22(1):149-59. PubMed ID: 23205468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A seamless phase I/II dose-finding trial assessing ingenol disoxate (LEO 43204) for field treatment of actinic keratosis on the scalp.
    Weiss J; Ulrich M; Bukhalo M; Østerdal ML; Bang B; Hanke CW
    Br J Dermatol; 2017 Jun; 176(6):1456-1464. PubMed ID: 28078678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A single-arm, open-label efficacy and tolerability study of diclofenac sodium 3% gel for the treatment of actinic keratosis of the upper and lower lip.
    Nelson CG; Spencer J; Nelson CG
    J Drugs Dermatol; 2007 Jul; 6(7):712-7. PubMed ID: 17763595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tolerability and safety profile of 12- to 28-week treatment with interferon beta-1b 250 and 500 microg QOD in patients with relapsing-remitting multiple sclerosis: a multicenter, randomized, double-blind, parallel-group pilot study.
    Hurwitz BJ; Jeffery D; Arnason B; Bigley K; Coyle P; Goodin D; Kaba S; Kirzinger S; Lynch S; Mandler R; Mikol D; Rammohan K; Sater R; Sriram S; Thrower B; Boateng F; Jakobs P; Wash MB; Bogumil T
    Clin Ther; 2008 Jun; 30(6):1102-12. PubMed ID: 18640466
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of a topical immune response modifier, resiquimod gel, to modify the recurrence rate of recurrent genital herpes: a pilot study.
    Spruance SL; Tyring SK; Smith MH; Meng TC
    J Infect Dis; 2001 Jul; 184(2):196-200. PubMed ID: 11424018
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microarray analysis of aberrant gene expression in actinic keratosis: effect of the Toll-like receptor-7 agonist imiquimod.
    Torres A; Storey L; Anders M; Miller RL; Bulbulian BJ; Jin J; Raghavan S; Lee J; Slade HB; Birmachu W
    Br J Dermatol; 2007 Dec; 157(6):1132-47. PubMed ID: 17944981
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of actinic keratoses with a novel betulin-based oleogel. A prospective, randomized, comparative pilot study.
    Huyke C; Reuter J; Rödig M; Kersten A; Laszczyk M; Scheffler A; Nashan D; Schempp C
    J Dtsch Dermatol Ges; 2009 Feb; 7(2):128-33. PubMed ID: 18808378
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of the efficacy and tolerability of 0.5% fluorouracil cream and 5% fluorouracil cream applied to each side of the face in patients with actinic keratosis.
    Loven K; Stein L; Furst K; Levy S
    Clin Ther; 2002 Jun; 24(6):990-1000. PubMed ID: 12117087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resiquimod: a new topical immune-response modifier for the treatment of actinic keratosis.
    Farr MA; Joshi TP; Lewis DJ
    Expert Opin Emerg Drugs; 2021 Dec; 26(4):433-434. PubMed ID: 34749552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Three times weekly tacrolimus ointment reduces relapse in stabilized atopic dermatitis: a new paradigm for use.
    Paller AS; Eichenfield LF; Kirsner RS; Shull T; Jaracz E; Simpson EL;
    Pediatrics; 2008 Dec; 122(6):e1210-8. PubMed ID: 19015204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of topical SR-T100 gel in treating actinic keratosis in Taiwan: A Phase III randomized double-blind vehicle-controlled parallel trial.
    Yang CC; Wong TW; Lee CH; Hong CH; Chang CH; Lai FJ; Lin SH; Chi CC; Lin TK; Yen H; Wu CH; Sheu HM; Lan CE
    J Dermatol Sci; 2018 Jun; 90(3):295-302. PubMed ID: 29530340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Randomized trial evaluating a new 0.5% fluorouracil formulation demonstrates efficacy after 1-, 2-, or 4-week treatment in patients with actinic keratosis.
    Jorizzo J; Stewart D; Bucko A; Davis SA; Espy P; Hino P; Rodriguez D; Savin R; Stough D; Furst K; Connolly M; Levy S
    Cutis; 2002 Dec; 70(6):335-9. PubMed ID: 12502122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Optimization of photodynamic therapy with a novel self-adhesive 5-aminolaevulinic acid patch: results of two randomized controlled phase III studies.
    Hauschild A; Stockfleth E; Popp G; Borrosch F; Brüning H; Dominicus R; Mensing H; Reinhold U; Reich K; Moor AC; Stocker M; Ortland C; Brunnert M; Szeimies RM
    Br J Dermatol; 2009 May; 160(5):1066-74. PubMed ID: 19222455
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Preventative effect of etretinate therapy on multiple actinic keratoses.
    Watson AB
    Cancer Detect Prev; 1986; 9(1-2):161-5. PubMed ID: 3524840
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aminolaevulinic acid diffusion characteristics in 'in vitro' normal human skin and actinic keratosis: implications for topical photodynamic therapy.
    McLoone N; Donnelly RF; Walsh M; Dolan OM; McLoone S; McKenna K; McCarron PA
    Photodermatol Photoimmunol Photomed; 2008 Aug; 24(4):183-90. PubMed ID: 18717959
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 5-fluorouracil 0.5% cream for multiple actinic or solar keratoses of the face and anterior scalp.
    Gupta AK; Weiss JS; Jorizzo JL
    Skin Therapy Lett; 2001 Jun; 6(9):1-4. PubMed ID: 11550079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bilateral comparison of the efficacy and tolerability of 3% diclofenac sodium gel and 5% 5-fluorouracil cream in the treatment of actinic keratoses of the face and scalp.
    Smith SR; Morhenn VB; Piacquadio DJ
    J Drugs Dermatol; 2006 Feb; 5(2):156-9. PubMed ID: 16485883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Topical 3% diclofenac in 2.5% hyaluronic acid gel: a review of its use in patients with actinic keratoses.
    Jarvis B; Figgitt DP
    Am J Clin Dermatol; 2003; 4(3):203-13. PubMed ID: 12627996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Novel treatment of chronic severe hand dermatitis with bexarotene gel.
    Hanifin JM; Stevens V; Sheth P; Breneman D
    Br J Dermatol; 2004 Mar; 150(3):545-53. PubMed ID: 15030340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Topical treatment of actinic keratoses with piroxicam 1% gel: a preliminary open-label study utilizing a new clinical score.
    Campione E; Diluvio L; Paternò EJ; Chimenti S
    Am J Clin Dermatol; 2010; 11(1):45-50. PubMed ID: 20000874
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.